TECNIS Multi-focal 3-pc, Model ZMA00
Johnson & Johnson Surgical Vision, Inc. · Decision date Oct 19, 2026
What did the FDA decide?
The FDA record for P080010/S032 covers the TECNIS Multi-focal 3-pc, Model ZMA00, a multifocal intraocular lens in the ophthalmic specialty under product code MFK, submitted by Johnson & Johnson Surgical Vision, Inc. The supplement is a 30-Day Notice filed under the reason Process Change - Manufacturer/Sterilizer/Packager/Supplier, and the recorded decision is OK30, dated 2026-10-19.
The recorded change is the transfer of microbiology testing from an external contractor to an in-house laboratory supporting product manufacturing at the AMO Puerto Rico manufacturing site. This notice concerns that testing-location change within the existing application; it is not a new approval of the lens itself. The public documentation includes no documents, so the notice's technical content and any FDA review detail beyond the recorded fields remain unknown.
Whether the in-house laboratory's methods, validation data or inspection outcome were assessed is not stated in the available record, and no clinical or legal conclusion about the device should be drawn from this administrative entry.
FDA approval order statement
the transfer of microbiology testing from an external contractor to an in-house laboratory to support product manufacturing at the AMO Puerto Rico manufacturing site
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Ophthalmic
- Decision date
- Oct 19, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P080010/S032
- Regulatory pathway
- PMA supplement
- Product code
- MFK
- Decision code
- OK30
- Decision date
- Oct 19, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Lens, multifocal intraocular.
- Product code
- MFK
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P080010. Subsequent supplements may change the device or its indications.
FDA decision timeline
P080010 · Original PMA
TECNIS MULTIFOCAL FOLDABLE POSTERIOR CHAMBER INTRAOCULAR LENS (IOL)
P080010/S032 received
Application receipt date recorded by FDA.
P080010/S032 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P080010. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P080010
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | PMA approval | Jan 16, 2009 | FDA |
Explore the linked device profile
Other records with product code MFK
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
ClearView HD intraocular lens (IOL)P200020/S013 | Lenstec, Inc. | PMA supplement | Oct 23, 2026 | FDA |
| Bausch + Lomb, Inc. | PMA supplement | Oct 23, 2026 | FDA | |
| Bausch + Lomb, Inc. | PMA supplement | Oct 14, 2026 | FDA | |
| Bausch + Lomb, Inc. | PMA supplement | Sep 30, 2026 | FDA | |
| Rayner Intraocular Lenses , Ltd. | PMA supplement | Sep 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Johnson & Johnson Surgical Vision, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 31 Technology Dr., Suite 200, Irvine, CA, 92618
Sources and methodology
- Original FDA record: P080010/S032
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



